a pharmaceutical distribution company
CV247Therapy for Doctors and Human Patients

Our cancer treatments for human patients using CV247Therapy are designed to manage their symptoms and possible side effects, by controlling the anti-tumour effects of this therapy, and to manage and improve the patients’ quality of life. Human patients have been benefiting from these treatments for many years, and in some cases go on to lead comparatively normal lives.

There have been several formal studies into the effects on human cancer therapies, including one study where 37 patients with progressive malignancy were seen by Dr Robert Thomas (Consultant Oncologist at Bedford Hospital and Addenbrokes) who also undertook a study of 110 patients with progressive prostate cancer over three years. These were followed up by study of 36 patients at a private clinic in Harrow, Middlesex where Dr Ros Taylor (Hospice of St Francis, Berkhamstead) carried out a series of tests.

We recommend that in all cases you should seek Medical Help before taking any medicine and refrain from any form of self-diagnosis.


Please contact us for more information on the availability of our cancer products for dog owners and human patients.

All enquiries are treated in strict confidence



CV247Therapy Representative Office: roger.wood@cvpharma.co.uk   |   Tel: +44 7778 213 337